retinoid X receptor


Also found in: Acronyms, Wikipedia.

retinoid X receptor

receptor for retinoic acids; has less affinity for retinoic acid than the retinoic acid receptors; function is not yet well understood.

retinoid X receptor

One of 2 receptors for retinoids; RXR plays a key role in organ development, in particular of the skin. Cf Retinoic acid receptor.

ret·i·noid X re·cep·tor

(ret'i-noyd rĕ-sep'tŏr)
Receptor for retinoic acids; has less affinity for retinoic acid than the retinoic acid receptors; function is not yet well understood.
References in periodicals archive ?
Scope - DelveInsight's report provides a Retinoid x receptors Beta (RXRs) Agonists Landscape across the globe - The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information - Coverage of the Retinoid x receptors Beta (RXRs) Agonists pipeline on the basis of target, MOA, route of administration, technology involved and molecule type - The report reviews key players involved in the therapeutics development for Retinoid x receptors Beta (RXRs) Agonists and also provide company profiling - Pipeline products coverage based on various stages of development from NDA filings to discovery.
called retinoid X receptors (RXRs) which play an important role in
The preclinical results announced today suggest that in addition to its other mechanisms of action, Targretin also acts to sensitize cancer cells to chemotherapy at the molecular level through its selective activation of retinoid X receptors.
The authors note that Targretin caused fewer side effects than other retinoids because it is the only drug that binds selectively to retinoid X receptors.
Targretin, a small organic compound discovered by Ligand scientists, selectively activates a subclass of retinoid receptors called retinoid X receptors (RXRs).
Discovered by Ligand scientists, Targretin (pronounced tar-GRET-tin) capsules and gel, generically known as bexarotene, contain a synthetic compound representing a novel class of retinoids that selectively activate retinoid X receptors (RXRs).
Targretin(TM) (LGD1069) is a compound discovered by Ligand scientists which selectively activates a subclass of retinoid receptors called retinoid X receptors (RXRs) which play an important role in several cellular activities.
Targretin, also known as LGD1069 (bexarotene), a synthetic retinoid analogue discovered by Ligand scientists, selectively activates a subclass of retinoid receptors called Retinoid X Receptors (RXR), which play an important role in the control of cellular functions.
Full browser ?